Custom Antibody Market Scope
Custom antibody provides high specificity & selectivity, these antibodies are easy to produce as compared to other antibodies & are hence the preferred choice in all types of research studies. Factors such as increasing research activity in life sciences industry along with increasing associations between industry & academic centers is driving the growth of the custom antibody market.one of the best benefit of custom antibody is that it accomplishes well in a qualitative or quantitative immuno detection method. The quality of catalog antibodies is also an area of concern in this market, & henceforth end users prefer custom-made antibodies.
According to AMA, the Global Custom Antibody market is expected to see growth rate of 8.88% and may see market size of USD480.96 Million by 2026.
Key players are adopting numerous strategy to gain market attention and to increase their market share, this strategy can be listed as increasing product portfolio, making partnership to adopt certain technologies and acquiring small players to finish competition in the future. As well as investing money in R&D sector to make up-gradations and innovation in product. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Custom Antibody market throughout the predicted period.
Thermo Fisher Scientific Inc. (United States), Bio-Rad Laboratories, Inc. (United States), Merck Group (Germany), Abcam plc (United Kingdom), Cell Signaling Technology, Inc. (United States), Agilent Technologies, Inc. (United States), GenScript (United States), BioLegend, Inc. (United States), Rockland Immunochemicals (United States) and ProMab Biotechnologies (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Innovagen AB (Sweden), ProteoGenix (United States) and Abgent (United States).
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.
The study have segmented the market of Global Custom Antibody market by Type (Monoclonal, Polyclonal and Recombinant) and Region with country level break-up.
On the basis of geography, the market of Custom Antibody has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
Prominent players are involved in new product launch by collaborating with other companies, I.e. Abcam launched the (PBS)-only recombinant antibodies and the new anti-PD-L1 antibody clone MKP1A07310 (clone 73-10) developed in collaboration with Merck KGaA in 2018
- Growing Industry-Academia Collaborations for Research Purpose
- Increasing Focus on Antibody-Drug Conjugates (ADCS)
- Development of Bispecific Antibodies
- Continuously Growing Research Activity and Related Funding
- Quality Concerns Over Catalog Antibodies
- Increasing Antibody Therapeutics and Expanding Drug Pipeline
- High Growth Opportunities in Emerging Countries
- Increasing Demand for Personalized Medicine and Protein Therapeutics
- Growth in Stem Cell and Cvd Research
- Increasing Focus on Biomarker Discovery
- Availability of the substitutes
- Cost- and Time-Intensive Antibody Development Processes
Key Target AudienceAntibiotics manufacturer, Raw material supplier, Traders/Distributors/Dealer, Industry Association, Governments and investment communities and Research organizations and associations